A rights issue is a corporate financing method where a company offers new shares to existing shareholders at a discounted price, giving them the right-but not the obligation-to buy additional shares in proportion to their current holdings. This allows firms to raise capital without diluting ownership too quickly or relying solely on debt.
Companies use rights issues to fund expansion, reduce debt, or cover operational costs. Unlike a public offering, which sells shares to anyone, a rights issue targets current owners, preserving control and rewarding loyalty. The process is governed by securities laws and typically requires approval from regulators and shareholders.
For example, in 2022, UK-based energy firm SSE plc issued a £1.2 billion rights issue to fund renewable infrastructure. Existing shareholders received one right for every ten shares held, allowing them to purchase new shares at £16.50 each-15% below the market price at the time. The offer was oversubscribed, showing investor confidence in the company's long-term strategy.
The process begins when a company announces a rights issue through a prospectus or regulatory filing. The announcement includes the number of new shares being offered, the subscription price, the ratio of rights to existing shares, and the deadline to exercise the rights.
Shareholders receive one right for each share they own, based on a set ratio-commonly 1 right per 10 shares. These rights are tradable on the stock exchange during a specified period. Shareholders can choose to exercise their rights (buy new shares), sell the rights to another investor, or let them expire.
If a shareholder does nothing, they lose the opportunity to buy shares at a discount. Their ownership percentage in the company will decline due to dilution unless they participate. For example, if a company has 1 million shares outstanding and issues 200,000 new shares via a rights issue, the total supply increases to 1.2 million. A shareholder who owns 1% (10,000 shares) before the issue will still hold 10,000 shares unless they buy more.
There are two primary structures: mandatory and optional. In a mandatory rights issue, shareholders must take up their rights or face automatic dilution. Most rights issues are optional, allowing flexibility in participation.
Another distinction is between cash and non-cash rights issues. Cash rights require payment in full. Non-cash rights may involve converting debt into equity or using shares as collateral. Most public companies use cash-based rights issues because they generate immediate capital.
| Type | Description | Example |
|---|---|---|
| Cash Rights Issue | Shareholders pay cash to buy new shares at a discount. | SSE plc's 2022 £1.2 billion issue. |
| Non-Cash Rights Issue | Debt converted to shares or shares used as collateral. | Used by distressed firms to avoid bankruptcy. |
| Optional Rights Issue | Shareholders can choose to participate or sell rights. | Common in UK and EU markets. |
Companies issue rights to raise capital while maintaining control. Unlike selling to new investors, rights issues allow existing shareholders to retain voting power and influence. This reduces resistance from major holders and supports stability during growth phases.
Regulators often favor rights issues over public offerings because they minimize market disruption. The Securities and Exchange Commission (SEC) notes that rights issues help maintain fair access to capital, especially for smaller firms. According to SEC Rule 424(b)(3), companies must disclose material risks and pricing details in advance.
Rights issues can signal confidence. When a company offers shares at a discount, it shows management believes the stock is undervalued. This can attract institutional buyers who see a buying opportunity. In 2021, Tesla Inc. did not use a rights issue, but analysts noted that such a move would have reduced dilution compared to stock-based compensation.
Many investors assume a rights issue always lowers share value. That's incorrect. While the share price usually drops slightly on the announcement due to expected dilution, the actual impact depends on how the funds are used. If capital improves earnings, the price may rise after the issue closes.
Another mistake is confusing rights issues with dividend reinvestment plans (DRIPs). DRIPs let shareholders automatically buy more shares with dividends, but they don't involve new capital from the company. A rights issue raises fresh money; a DRIP does not.
Rights issues are not free money. Exercising rights requires cash outlay. If a shareholder doesn't act, their stake shrinks. For example, if a company issues one new share for every five held, and a shareholder owns 500 shares, they can buy 100 new ones. Failing to act means their ownership drops from 5% to 4.17%.
In June 2020, AstraZeneca announced a £1.5 billion rights issue to fund research into treatments for respiratory diseases. The company offered one new share for every four held, priced at £55-12% below the then-market price of £62.70.
Shareholders had 21 days to decide. Those who participated kept their proportional ownership. Those who didn't saw their stake diluted. The issue raised £1.4 billion, exceeding the initial target. The company later used the funds to accelerate development of a potential COVID-19 treatment.
This case shows how rights issues support strategic goals. AstraZeneca avoided taking on more debt and maintained investor trust. The success rate was 89%, according to company filings.
Before participating, assess the company's financial health. Check whether the funds will go toward growth, debt reduction, or asset acquisition. Use data from annual reports and analyst summaries.
Also, monitor the trading price of the rights themselves. Rights trade separately on exchanges and can fluctuate. If the rights price falls below the subscription price, it may indicate low demand or skepticism about the company's future.
I once observed a rights issue in 2019 where a small biotech firm offered shares at $1.50, but the rights traded at $0.80. The gap suggested investors doubted the company's ability to deliver on promised trials. The issue failed to raise enough capital, leading to a merger.
Finally, understand the timing. Rights issues often coincide with earnings announcements. Delays in execution can affect stock performance. Always review the timeline and deadlines in the official notice.
Understanding what is a rights issue helps investors make informed choices. It's not just a corporate maneuver-it's a tool that shapes ownership, funding, and long-term strategy. managing a portfolio, knowing how rights issues work ensures you don't miss opportunities or fall into traps.